A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
Author:
Funder
Canadian Cancer Society
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-019-05381-y.pdf
Reference45 articles.
1. Levy JMM, Towers CG, Thorburn A (2017) Targeting autophagy in cancer. Nat Rev Cancer 17:528–542. https://doi.org/10.1038/nrc.2017.53
2. Zheng K, He Z, Kitazato K, Wang Y (2019) Selective autophagy regulates cell cycle in cancer therapy. Theranostics 9:104–125. https://doi.org/10.7150/thno.30308
3. Chude CI, Amaravadi RK (2017) Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci 18(6):1279. https://doi.org/10.3390/ijms18061279
4. Papanagnou P, Papadopoulos GE, Stivarou T, Pappas A (2019) Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology. OncoTargets Ther 12:319–339. https://doi.org/10.2147/OTT.S182685
5. Zhang Y, Liao Z, Zhang L, Xiao H (2015) The utility of chloroquine in cancer therapy. Curr Med Res Opin 31:1009–1013. https://doi.org/10.1185/03007995.2015.1025731
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy;Proceedings of the National Academy of Sciences;2023-11-27
2. Bioevaluation of Spiro N‐Propargylic β‐Enaminones as Anti‐Breast Cancer Agents: In Vitro and Molecular Docking Studies;Chemistry & Biodiversity;2023-11
3. Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review;Annals of Pharmacotherapy;2023-10-26
4. Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines;Pharmacology & Therapeutics;2023-09
5. The new insights into autophagy in thyroid cancer progression;Journal of Translational Medicine;2023-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3